Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells
The FEBS Journal · 2025
DOI: 10.1111/febs.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Baoxin Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Key Laboratory of Cellular and Molecular Immunology in Tianjin, and Key Laboratory of Immune Microen…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis, Micrococcal Nuclease. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Incubation Project of Tianjin University Sichuan Innovation Institute, National Key Research and Development Program of China, Tianjin Second Batch of High-Level Personnel Selection Project in Health Sector.
Abstract (Originalsprache)
Several liver diseases have been associated with the Tudor staphylococcal nuclease (Tudor‐SN) protein. Our previous results demonstrated that, in comparison to wild‐type (WT) mice, systemic overexpression of Tudor‐SN in transgenic (Tg) mice (Tudor‐SN‐Tg) ameliorates obesity‐induced insulin resistance and hepatic steatosis. In this study, we observed an inverse correlation in the expression levels of Tudor‐SN and profibrogenic factors, such as alpha‐smooth muscle actin (α‐SMA) and collagen alpha‐1(I) chain (COL1A1), in liver tissue samples between Tudor‐SN‐Tg and WT mice. The correlation was further validated in hepatic fibrotic tissues from patients with cirrhosis and fibrosis. Utilizing a carbon tetrachloride (CCl 4 )‐induced hepatic fibrosis model, we observed that Tudor‐SN attenuated hepatic fibrosis in mice. Tudor‐SN was abundantly expressed in hepatic stellate cells (HSCs). In the Tudor‐SN‐Tg group, primary HSCs showed stellate‐like morphology as well as reduced in vitro proliferation and chemotactic ability compared to the WT group. Pseudotime series analysis of HSCs further showed the role of Tudor‐SN during the dynamic evolution of HSC activation. Reduced Tudor‐SN expression facilitated the in vitro activation of LX‐2 cells. Furthermore, primary HSC cells from WT and Tudor‐SN knockout (KO) mice were isolated for RNA‐sequencing analysis. The findings suggested that Tudor‐SN may regulate the activation of primary HSCs by influencing lipid metabolism, translation initiation, immune response, and the extracellular matrix. In summary, we identified Tudor‐SN as a newly identified regulator involved in the transition of quiescent HSCs to activated states, shedding light on the antifibrotic impact of Tudor‐SN expression in the development of hepatic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, Key Laboratory of Cellular and Molecular Immunology in Tianjin, and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Minist…
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Tianjin Medical University, China.
- Department of Immunology, School of Basic Medical Science, Tianjin Medical University, China.
- Department of Gastroenterology and Hepatology, Nankai University Affinity the Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology R…
- Department of Medical Laboratory, Tianjin Hospital, Tianjin University, China.
- Tianjin Key Laboratory of Molecular Diagnosis and Treatment of Liver Cancer, Tianjin First Central Hospital, China.
ORCID-Profile: Fengmei Wang, Xingjie Gao, Jie Yang
Förderung
- Incubation Project of Tianjin University Sichuan Innovation Institute
- National Key Research and Development Program of China
- Tianjin Second Batch of High-Level Personnel Selection Project in Health Sector
- National Natural Science Foundation of China
- Key Project of Tianjin Natural Science Foundation
- Tianjin Key Medical Discipline (Specialty) Construction Project
- Excellent Talent Project of Tianjin Medical University
Zitieren
APA
Qian, B., Zhao, Y., Zhang, X., Zhao, C., Cui, X., Wang, F., Jing, X., Ge, L., Yao, Z., Gao, X., & Yang, J. (2025). Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells. The FEBS Journal. https://doi.org/10.1111/febs.70073
Vancouver
Qian B, Zhao Y, Zhang X, Zhao C, Cui X, Wang F, et al. Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells. The FEBS Journal. 2025. doi:10.1111/febs.70073
BibTeX
@article{Qian2025,
author = {Qian, Baoxin and Zhao, Yan and Zhang, Xinxin and Zhao, Chunyan and Cui, Xiaoteng and Wang, Fengmei and Jing, Xiang and Ge, Lin and Yao, Zhi and Gao, Xingjie and Yang, Jie},
title = {Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70073}
}
EUVIMED